These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 27125058

  • 1. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
    Peacock GF, Sauvageot J, Hill A, Killian A.
    Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
    [Abstract] [Full Text] [Related]

  • 2. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K, Hutchinson DJ, Chablani L.
    Am J Health Syst Pharm; 2018 May 01; 75(9):e236-e240. PubMed ID: 29691267
    [Abstract] [Full Text] [Related]

  • 3. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ, Liou Y, Best R, Zhao F.
    Ann Pharmacother; 2010 Mar 01; 44(3):462-5. PubMed ID: 20150505
    [Abstract] [Full Text] [Related]

  • 4. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K, Winnicka K, Czajkowska-Kośnik A.
    Acta Pol Pharm; 2009 Mar 01; 66(3):321-6. PubMed ID: 19645333
    [Abstract] [Full Text] [Related]

  • 5. Effect of buffer and antioxidant on stability of a mercaptopurine suspension.
    Aliabadi HM, Romanick M, Desai S, Lavasanifar A.
    Am J Health Syst Pharm; 2008 Mar 01; 65(5):441-7. PubMed ID: 18281736
    [Abstract] [Full Text] [Related]

  • 6. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J, Gervase MA, Evans J, Deville R, Dong X.
    PLoS One; 2021 Mar 01; 16(8):e0255963. PubMed ID: 34375349
    [Abstract] [Full Text] [Related]

  • 7. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS, Haribhakti RP, Parker GA.
    Am J Hosp Pharm; 1991 Jun 01; 48(6):1241-4. PubMed ID: 1858804
    [Abstract] [Full Text] [Related]

  • 8. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
    Cober MP, Johnson CE.
    Am J Health Syst Pharm; 2007 Mar 15; 64(6):644-6. PubMed ID: 17353574
    [Abstract] [Full Text] [Related]

  • 9. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.
    Graves RA, Mandal TK, Bostanian LA, Nguyen AT, Swopes D, Morris TC, Pramar YV.
    Int J Pharm Compd; 2019 Mar 15; 23(6):519-527. PubMed ID: 31751949
    [Abstract] [Full Text] [Related]

  • 10. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ, Johnson CE, Klein KC.
    Am J Health Syst Pharm; 2009 Apr 01; 66(7):665-7. PubMed ID: 19299374
    [Abstract] [Full Text] [Related]

  • 11. Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt.
    Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Morris TC, Graves RA.
    Int J Pharm Compd; 2019 Apr 01; 23(2):157-162. PubMed ID: 31085781
    [Abstract] [Full Text] [Related]

  • 12. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
    Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA.
    Int J Pharm Compd; 2021 Apr 01; 25(2):169-175. PubMed ID: 33798117
    [Abstract] [Full Text] [Related]

  • 13. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.
    Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA.
    Int J Pharm Compd; 2020 Apr 01; 24(5):413-419. PubMed ID: 32886640
    [Abstract] [Full Text] [Related]

  • 14. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
    Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Miller V, Morris TC, Graves RA.
    Int J Pharm Compd; 2019 Apr 01; 23(1):70-76. PubMed ID: 30668538
    [Abstract] [Full Text] [Related]

  • 15. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
    Zhang YP, Trissel LA, Fox JL.
    Int J Pharm Compd; 2000 Apr 01; 4(1):69-71. PubMed ID: 23985892
    [Abstract] [Full Text] [Related]

  • 16. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y, Chin ZW, Ellis D, Lwin EMP, Turner S, Williams D, Garg S.
    Am J Health Syst Pharm; 2018 Mar 01; 75(5):309-315. PubMed ID: 29472513
    [Abstract] [Full Text] [Related]

  • 17. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D, Lin SW, Brown H, Sangaroomthong A, Shin D, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z.
    Int J Pharm Compd; 2018 Mar 01; 22(2):164-171. PubMed ID: 29877863
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP, Johnson CE, Sudekum D, Penprase K.
    Am J Health Syst Pharm; 2011 May 01; 68(9):843-5. PubMed ID: 21515869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.